{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:16:40Z","timestamp":1789139800925,"version":"build-2803163510"},"reference-count":157,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Metabolic-Associated Fatty Liver Disease (MAFLD) is the most common cause of chronic liver disease and also a major contributor to liver disease-related complications and mortality. It is closely associated with cardiovascular disease (CVD), stroke, type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD), and non-liver tumors, and has become a significant global public health issue. In recent years, studies have respectively revealed the relationships between the cGAS\/STING and STING\/NF-\u03baB signaling pathways and MAFLD. Although, in addition to cyclic GMP-AMP synthase (cGAS), various other DNA sensors can also recognize DNA molecules and activate stimulator of interferon genes (STING), their localization response capability and hepatocyte targeting are relatively weak, and most of them only function in specific cell types or physiological states. As a key innate immune mediator, cGAS is the core molecule that activates the classical STING pathway. Therefore, the cGAS\/STING\/NF-\u03baB signaling pathway may form an important pathological chain of \u201cDNA stress - inflammation - metabolic abnormality\u201d in MAFLD. Consequently, it is necessary to explore the mechanism of action and research progress of the cGAS\/STING\/NF-\u03baB signaling pathway in MAFLD, which provides new insights for the mechanism research and treatment of MAFLD.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1674018","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:26:21Z","timestamp":1759123581000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Exploring the pathogenesis of MAFLD from an immunological perspective: from the perspective of the cGAS\/STING\/NF-\u03baB signaling pathway"],"prefix":"10.3389","volume":"16","author":[{"given":"Ruiyuan","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000251","article-title":"The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019","volume":"7","author":"Paik","year":"2023","journal-title":"Hepatol Commun"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn501113-20240327-00163","article-title":"Guidelines for the Prevention and Treatment of Metabolic-Associated (Non-Alcoholic) Fatty Liver Disease (2024 Version)","volume":"32","year":"2024","journal-title":"Chin J Hepatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1159\/000541386","article-title":"EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"17","year":"2024","journal-title":"Obes Facts"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.07.021","article-title":"Can we use old NAFLD data under the new MASLD definition","volume":"80","author":"Song","year":"2024","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.02.030","article-title":"Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults","volume":"20","author":"Liu","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.cgh.2024.03.006","article-title":"The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among patients with type 2 diabetes","volume":"22","author":"Younossi","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/apt.17096","article-title":"Meta-analysis: global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000-2021","volume":"56","author":"Li","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i3.549","article-title":"Metabolic dysfunction associated fatty liver disease: The new nomenclature and its impact","volume":"29","author":"Tang","year":"2023","journal-title":"World J Gastroenterol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-024-10662-w","article-title":"Metabolic dysfunction associated fatty liver disease in healthy weight individuals","volume":"18","author":"M\u00e9ndez-S\u00e1nchez","year":"2024","journal-title":"Hepatol Int"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcmgh.2022.03.006","article-title":"Macrophage SCAP contributes to metaflammation and lean NAFLD by activating STING-NF-\u03baB signaling pathway","volume":"14","author":"Huang","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13069","article-title":"Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999-2016","volume":"288","author":"Zou","year":"2020","journal-title":"J Intern Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia","volume":"67","author":"Fan","year":"2017","journal-title":"J Hepatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111629","article-title":"Pathophysiological molecular mechanisms of obesity: A link between MAFLD and NASH with cardiovascular diseases","volume":"22","author":"Guti\u00e9rrez-Cuevas","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-331003","article-title":"Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease","volume":"73","author":"Lee","year":"2024","journal-title":"Gut"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67663-5","article-title":"Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: A case-control study","volume":"366","author":"Yusuf","year":"2005","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.5.1219","article-title":"Early signs of cardiovascular disease in youth with obesity and type 2 diabetes","volume":"28","author":"Gungor","year":"2005","journal-title":"Diabetes Care"},{"key":"B20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1353\/hpu.2011.0166","article-title":"Relationships between obesity and cardiovascular diseases in four southern states and Colorado","volume":"22","author":"Akil","year":"2011","journal-title":"J Health Care Poor Underserved"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3407306","article-title":"The impact of obesity on the cardiovascular system","volume":"2018","author":"Csige","year":"2018","journal-title":"J Diabetes Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2022.03.016","article-title":"Metabolic associated fatty liver disease increases the risk of systemic complications and mortality. A meta-analysis and systematic review of 12\u2009620\u2009736 individuals","volume":"28","author":"Quek","year":"2022","journal-title":"Endocr Pract"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2010.07.022","article-title":"Nonalcoholic steatohepatitis and increased risk of chronic kidney disease","volume":"60","author":"Yasui","year":"2011","journal-title":"Metabolism"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02623","article-title":"Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease","volume":"32","author":"MaChado","year":"2012","journal-title":"Liver Int"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e032604","DOI":"10.1161\/JAHA.123.032604","article-title":"Severity and remission of metabolic dysfunction-associated fatty\/steatotic liver disease with chronic kidney disease occurrence","volume":"13","author":"Gao","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2021.100149","article-title":"Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)","volume":"12","author":"Zarghamravanbakhsh","year":"2021","journal-title":"Metab Open"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-019-09982-z","article-title":"Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosis","volume":"13","author":"Wang","year":"2019","journal-title":"Hepatol Int"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7120562","article-title":"Lean patients with non-alcoholic fatty liver disease have a severe histological phenotype similar to obese patients","volume":"7","author":"Denkmayr","year":"2018","journal-title":"J Clin Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e31826be328","article-title":"The severity of histologic liver lesions is independent of body mass index in patients with nonalcoholic fatty liver disease","volume":"47","author":"Margariti","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32381","article-title":"Discovery of an insulin-induced gene binding compound that ameliorates nonalcoholic steatohepatitis by inhibiting sterol regulatory element-binding protein-mediated lipogenesis","volume":"76","author":"Jiang","year":"2022","journal-title":"Hepatology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.09.037","article-title":"Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis","volume":"74","author":"Mohs","year":"2021","journal-title":"J Hepatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.02.025","article-title":"Inhibition of PU.1 ameliorates metabolic dysfunction and non-alcoholic steatohepatitis","volume":"73","author":"Liu","year":"2020","journal-title":"J Hepatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-01112-7","article-title":"Regulation of cGAS-STING signalling and its diversity of cellular outcomes","volume":"25","author":"Zhang","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3760\/cma.J.c.n141217-20211227-00521","article-title":"Research Progress on Interferon Gene Stimulating Factors and Type I interferon diseases","volume":"26","author":"Zhang","year":"2022","journal-title":"Chin J Rheumatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nri3133","article-title":"Immunomodulatory functions of type I interferons","volume":"12","author":"Gonz\u00e1lez-Navajas","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.84890","article-title":"The role of cGAS-STING signalling in metabolic diseases: from signalling networks to targeted intervention","volume":"20","author":"Gong","year":"2024","journal-title":"Int J Biol Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e33093","article-title":"The role of the cGAS-STING pathway in metabolic diseases","volume":"10","author":"Xu","year":"2024","journal-title":"Heliyon"},{"key":"B40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.coi.2015.07.003","article-title":"Type 2 responses at the interface between immunity and fat metabolism","volume":"36","author":"Odegaard","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/hep.29777","article-title":"Disruption of adenosine 2A receptor exacerbates NAFLD through increasing inflammatory responses and SREBP1c activity","volume":"68","author":"Cai","year":"2018","journal-title":"Hepatology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e009590","DOI":"10.1136\/jitc-2024-009590","article-title":"Interferon-induced factor 16 is essential in metastatic melanoma to maintain STING levels and the immune responses upon IFN-\u03b3 response pathway activation","volume":"12","author":"Kobayashi","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e170532","DOI":"10.1172\/jci.insight.170532","article-title":"Cell cycle inhibitors activate the hypoxia-induced DDX41\/STING pathway to mediate antitumor immune response in liver cancer","volume":"9","author":"Wong","year":"2024","journal-title":"JCI Insight"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/nature06013","article-title":"DAI (DLM-1\/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response","volume":"448","author":"Takaoka","year":"2007","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/nature06537","article-title":"TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines","volume":"451","author":"Ishii","year":"2008","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06889-6","article-title":"MRE11 liberates cGAS from nucleosome sequestration during tumorigenesis","volume":"625","author":"Cho","year":"2024","journal-title":"Nature"},{"key":"B47","doi-asserted-by":"publisher","first-page":"eabf9441","DOI":"10.1126\/sciadv.abf9441","article-title":"MRE11-dependent instability in mitochondrial DNA fork protection activates a cGAS immune signaling pathway","volume":"7","author":"Luzwick","year":"2021","journal-title":"Sci Adv"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1222694110","article-title":"DNA damage sensor MRE11 recognizes cytosolic double-stranded DNA and induces type I interferon by regulating STING trafficking","volume":"110","author":"Kondo","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e00047","DOI":"10.7554\/eLife.00047","article-title":"DNA-PK is a DNA sensor for IRF-3-dependent innate immunity","volume":"1","author":"Ferguson","year":"2012","journal-title":"Elife"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1080\/23723556.2018.1558682","article-title":"cGAS-independent STING activation in response to DNA damage","volume":"6","author":"Unterholzner","year":"2019","journal-title":"Mol Cell Oncol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2014.06.006","article-title":"The mechanism of double-stranded DNA sensing through the cGAS-STING pathway","volume":"25","author":"Shu","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-019-0151-1","article-title":"DNA sensing by the cGAS-STING pathway in health and disease","volume":"20","author":"Motwani","year":"2019","journal-title":"Nat Rev Genet"},{"key":"B53","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.cell.2019.05.036","article-title":"STING polymer structure reveals mechanisms for activation, hyperactivation, and inhibition","volume":"178","author":"Ergun","year":"2019","journal-title":"Cell"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.12182\/20210560501","article-title":"Mitochondrial DNA and cGAS-STING innate immune signaling pathway: latest research progress","volume":"52","author":"Li","year":"2021","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102691","article-title":"STING mediates hepatocyte pyroptosis in liver fibrosis by Epigenetically activating the NLRP3 inflammasome","volume":"62","author":"Xiao","year":"2023","journal-title":"Redox Biol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12072-020-10121-2","article-title":"How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease","volume":"15","author":"Geng","year":"2021","journal-title":"Hepatol Int"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.02.019","article-title":"New frontiers in the cGAS-STING intracellular DNA-sensing pathway","volume":"57","author":"Dvorkin","year":"2024","journal-title":"Immunity"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2024.10.011","article-title":"TFEB links the cGAS-STING pathway to lysosome biogenesis","volume":"34","author":"Meng","year":"2024","journal-title":"Trends Cell Biol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021","article-title":"The cytosolic DNA-sensing cGAS-STING pathway in liver diseases","volume":"9","author":"Wang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111868","article-title":"The Golgi-resident protein ACBD3 concentrates STING at ER-Golgi contact sites to drive export from the ER","volume":"41","author":"Motani","year":"2022","journal-title":"Cell Rep"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.11.009","article-title":"Macrophages steal STING from the infectious disease playbook to promote nonalcoholic fatty liver disease","volume":"155","author":"Maher","year":"2018","journal-title":"Gastroenterology"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.09.010","article-title":"Expression of STING is increased in liver tissues from patients with NAFLD and promotes macrophage-mediated hepatic inflammation and fibrosis in mice","volume":"155","author":"Luo","year":"2018","journal-title":"Gastroenterology"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.2337\/dbi18-0052","article-title":"The cGAS-cGAMP-STING pathway: a molecular link between immunity and metabolism","volume":"68","author":"Bai","year":"2019","journal-title":"Diabetes"},{"key":"B65","doi-asserted-by":"publisher","first-page":"154519","DOI":"10.1016\/j.cyto.2018.08.013","article-title":"The role of IFN in the development of NAFLD and NASH","volume":"124","author":"Mohlenberg","year":"2019","journal-title":"Cytokine"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2022.00067","article-title":"Reactive oxygen species and oxidative stress in the pathogenesis of MAFLD","volume":"10","author":"Clare","year":"2022","journal-title":"J Clin Transl Hepatol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00524-z","article-title":"The cGAS-STING pathway as a therapeutic target in inflammatory diseases","volume":"21","author":"Decout","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41575-020-00366-5","article-title":"Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors","volume":"18","author":"Francque","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1356","article-title":"Liver macrophages: Old dogmas and new insights","volume":"3","author":"Guillot","year":"2019","journal-title":"Hepatol Commun"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2200351","article-title":"cGAS Mediates Inflammation by Polarizing Macrophages to M1 Phenotype via the mTORC1 Pathway","volume":"210","author":"Shen","year":"2023","journal-title":"J Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-019-0044-9","article-title":"Liver macrophages regulate systemic metabolism through non\u2043inflammatory factors","volume":"1","author":"Morgantini","year":"2019","journal-title":"Nat Metab"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.2337\/db09-0016","article-title":"De-pletion of liver Kupffer cells prevents the development of Diet-induced hepatic steatosis and insulin resistance","volume":"59","author":"Huang","year":"2010","journal-title":"Diabetes"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2009.05.070","article-title":"Criti-cal role of Kupffer cells in the management of diet -induced diabetes and obesity","volume":"385","author":"Neyrinck","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.417014","article-title":"Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-\u03b1 production","volume":"287","author":"Tosello-Trampont","year":"2012","journal-title":"J Biol Chem"},{"key":"B75","doi-asserted-by":"publisher","first-page":"10:e67358","DOI":"10.7554\/eLife.67358","article-title":"Drosophila STING protein has a role in lipid metabolism","author":"Akhmetova","year":"2021","journal-title":"Elife"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2015.02.003","article-title":"Endoplasmic reticulum stress response in non-alcoholic steatohepatitis: the possible role of physical exercise","volume":"64","author":"Passos","year":"2015","journal-title":"Metabolism"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3109\/10715762.2015.1078461","article-title":"Endoplasmic reticulum stress and oxidative stress in the pathogenesis of non-alcoholic fatty liver disease","volume":"49","author":"Ashraf","year":"2015","journal-title":"Free Radic Res"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.592129","article-title":"The molecular mechanisms underlying mitochondria-associated endoplasmic reticulum membrane-induced insulin resistance","volume":"11","author":"Cheng","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B79","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12964-023-01393-w","article-title":"Hyperglycemia-induced STING signaling activation leads to aortic endothelial injury in diabetes","volume":"21","author":"An","year":"2023","journal-title":"Cell Commun Signal"},{"key":"B80","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41420-023-01425-x","article-title":"High glucose-induced STING activation inhibits diabetic wound healing through promoting M1 polarization of macrophages","volume":"9","author":"Geng","year":"2023","journal-title":"Cell Death Discov"},{"key":"B81","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s10020-023-00769-5","article-title":"ALDH2 mitigates LPS-induced cardiac dysfunction, inflammation, and apoptosis through the cGAS\/STING pathway","volume":"29","author":"Liu","year":"2023","journal-title":"Mol Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9050957","article-title":"Gut microbiota and NAFLD: pathogenetic mechanisms, microbiota signatures, and therapeutic interventions","volume":"9","author":"Hrncir","year":"2021","journal-title":"Microorganisms"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2020.00131","article-title":"Gut microbiota in metabolic-associated fatty liver disease and in other chronic metabolic diseases","volume":"9","author":"Hern\u00e1ndez-Ceballos","year":"2021","journal-title":"J Clin Transl Hepatol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/ni0111-5","article-title":"Diet, gut microbiota and immune responses","volume":"12","author":"Maslowski","year":"2011","journal-title":"Nat Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/nature12820","article-title":"Diet rapidly and reproducibly alters the human gut microbiome","volume":"505","author":"David","year":"2014","journal-title":"Nature"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s00248-018-1198-9","article-title":"High-fat diet consumption induces microbiota dysbiosis and intestinal inflammation in zebrafish","volume":"76","author":"Arias-Jayo","year":"2018","journal-title":"Microb Ecol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.117.309017","article-title":"STING-IRF3 triggers endothelial inflammation in response to free fatty acid-induced mitochondrial damage in diet-induced obesity","volume":"37","author":"Mao","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00919","article-title":"Diet rich in animal protein promotes pro-inflammatory macrophage response and exacerbates colitis in mice","volume":"10","author":"Kostovcikova","year":"2019","journal-title":"Front Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3390\/cells9122701","article-title":"Diet rich in simple sugars promotes pro-inflammatory response via gut microbiota alteration and TLR4 signaling","volume":"9","author":"Fajstova","year":"2020","journal-title":"Cells"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.12.018","article-title":"The short chain fatty acid butyrate imprints an antimicrobial program in macrophages","volume":"50","author":"Schulthess","year":"2019","journal-title":"Immunity"},{"key":"B91","doi-asserted-by":"publisher","first-page":"e0281721","DOI":"10.1128\/mBio.02817-21","article-title":"Toll-like receptor (TLR) signaling enables cyclic GMP-AMP synthase (cGAS) sensing of HIV-1 infection in macrophages","volume":"12","author":"Siddiqui","year":"2021","journal-title":"mBio"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111132","article-title":"Activation of cGAS-STING signaling pathway promotes liver fibrosis and hepatic sinusoidal microthrombosis","volume":"125","author":"Luo","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41419-019-2101-4","article-title":"MKL1 promotes endothelial-to-mesenchymal transition and liver fibrosis by activating TWIST1 transcription","volume":"10","author":"Li","year":"2019","journal-title":"Cell Death Dis"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.983255","article-title":"Liver sinusoidal endothelial cell expressed vascular cell adhesion molecule 1 promotes liver fibrosis","volume":"13","author":"Guo","year":"2022","journal-title":"Front Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2020.12.007","article-title":"Single-cell transcriptomics reveals zone-specific alterations of liver sinusoidal endothelial cells in cirrhosis","volume":"11","author":"Su","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.cmet.2019.08.003","article-title":"Mitochondrial damage and activation of the STING pathway lead to renal inflammation and fibrosis","volume":"30","author":"Chung","year":"2019","journal-title":"Cell Metab"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-023-02448-5","article-title":"Cytosolic mtDNA-cGAS-STING axis contributes to sepsis-induced acute kidney injury via activating the NLRP3 inflammasome","volume":"28","author":"Luo","year":"2024","journal-title":"Clin Exp Nephrol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2019.07.013","article-title":"Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know","volume":"19","author":"Kiapidou","year":"2020","journal-title":"Ann Hepatol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1047794","article-title":"Association of metabolic dysfunction-associated fatty liver disease, type 2 diabetes mellitus, and metabolic goal achievement with risk of chronic kidney disease","volume":"10","author":"Su","year":"2022","journal-title":"Front Public Health"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjab066","article-title":"cGAS\u2013STING signaling and function in metabolism and kidney diseases","volume":"13","author":"Bai","year":"2021","journal-title":"J Mol Cell Biol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-022-00589-6","article-title":"Role of the cGAS-STING pathway in systemic and organ-specific diseases","volume":"18","author":"Skopelja-Gardner","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1708744114","article-title":"DsbA-L prevents obesity-induced inflammation and insulin resistance by suppressing the mtDNA release-activated cGAS-cGAMP-STING pathway","volume":"114","author":"Bai","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-023-01216-1","article-title":"DsbA-L ameliorates renal aging and renal fibrosis by maintaining mitochondrial homeostasis","volume":"45","author":"Yang","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"B104","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1038\/s41467-020-18304-z","article-title":"DsbA-L mediated renal tubulointerstitial fibrosis in UUO mice","volume":"11","author":"Li","year":"2020","journal-title":"Nat Commun"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn441217-20200916-00054","article-title":"Research progress on the activation mechanism of the CGAS-cGAMP-STING signaling pathway and its role in kidney diseases","volume":"37","author":"Liu","year":"2021","journal-title":"Chin J Nephrol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3390\/ph15101241","article-title":"The STING in non-alcoholic fatty liver diseases: potential therapeutic targets in inflammation-carcinogenesis pathway","volume":"15","author":"Lv","year":"2022","journal-title":"Pharm (Basel)"},{"key":"B107","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.metabol.2017.09.010","article-title":"Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease","volume":"81","author":"Qiao","year":"2018","journal-title":"Metabolism"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1308331110","article-title":"STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease","volume":"110","author":"Petrasek","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B109","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jaci.2020.07.027","article-title":"Mutual regulation of metabolic processes and proinflammatory NF-\u03baB signaling","volume":"146","author":"Kracht","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines6020058","article-title":"The crosstalk of endoplasmic reticulum (ER) stress pathways with NF-\u03baB: complex mechanisms relevant for cancer, inflammation and infection","volume":"6","author":"Schmitz","year":"2018","journal-title":"Biomedicines"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M502493200","article-title":"Activation of NF-kappaB by extracellular matrix is involved in spreading and glucose-stimulated insulin secretion of pancreatic beta cells","volume":"280","author":"Hammar","year":"2005","journal-title":"J Biol Chem"},{"key":"B112","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12876-015-0325-z","article-title":"Moderate activation of IKK2-NF-kB in unstressed adult mouse liver induces cytoprotective genes and lipogenesis without apparent signs of inflammation or fibrosis","volume":"15","author":"Lu","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cell.2008.07.043","article-title":"Hypothalamic IKKbeta\/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity","volume":"135","author":"Zhang","year":"2008","journal-title":"Cell"},{"key":"B114","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2010.12.008","article-title":"NF-\u03baB, inflammation, and metabolic disease","volume":"13","author":"Baker","year":"2011","journal-title":"Cell Metab"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101349","article-title":"The hepatocyte IKK: NF-\u03baB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis","volume":"54","author":"Heida","year":"2021","journal-title":"Mol Metab"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"B117","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1231520","article-title":"Study on inflammation and fibrogenesis in MAFLD from 2000 to 2022: a bibliometric analysis","volume":"14","author":"Luo","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2394588","article-title":"The crucial roles and research advances of cGAS-STING pathway in liver diseases","volume":"56","author":"Zhang","year":"2024","journal-title":"Ann Med"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-024-01417-0","article-title":"ATM and IRAK1 orchestrate two distinct mechanisms of NF-\u03baB activation in response to DNA damage","volume":"32","author":"Bournique","year":"2025","journal-title":"Nat Struct Mol Biol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.immuni.2024.02.004","article-title":"The transcription factor NF-\u03baB orchestrates nucleosome remodeling during the primary response to Toll-like receptor 4 signaling","volume":"57","author":"Feng","year":"2024","journal-title":"Immunity"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02742-3","article-title":"Disruption of DNA-PKcs-mediated cGAS retention on damaged chromatin potentiates DNA damage-inducing agent-induced anti-multiple myeloma activity","volume":"131","author":"Zhang","year":"2024","journal-title":"Br J Cancer"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-00422-4","article-title":"Structural basis for nucleosome-mediated inhibition of cGAS activity","volume":"30","author":"Cao","year":"2020","journal-title":"Cell Res"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112185","article-title":"NF-\u03baB activation enhances STING signaling by altering microtubule-mediated STING trafficking","volume":"42","author":"Zhang","year":"2023","journal-title":"Cell Rep"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2023.00197","article-title":"Update on the STING signaling pathway in developing nonalcoholic fatty liver disease","volume":"12","author":"Liu","year":"2024","journal-title":"J Clin Transl Hepatol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"e2208934119","DOI":"10.1073\/pnas.2208934119","article-title":"Modulation of cGAS-STING signaling by PPAR\u03b1 in a mouse model of ischemia-induced retinopathy","volume":"119","author":"Ma","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.746964","article-title":"Tanreqing inhibits LPS-induced acute lung injury in vivo and in vitro through downregulating STING signaling pathway","volume":"12","author":"He","year":"2021","journal-title":"Front Pharmacol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-021-09692-z","article-title":"Lipotoxicity-induced mtDNA release promotes diabetic cardiomyopathy by activating the cGAS-STING pathway in obesity-related diabetes","volume":"39","author":"Ma","year":"2023","journal-title":"Cell Biol Toxicol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115184","article-title":"Design and syntheses of a bimolecular STING agonist based on the covalent STING antagonist","volume":"250","author":"Zang","year":"2023","journal-title":"Eur J Med Chem"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15673","article-title":"The STING antagonist H-151 ameliorates psoriasis via suppression of STING\/NF-\u03baB-mediated inflammation","volume":"178","author":"Pan","year":"2021","journal-title":"Br J Pharmacol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26093933","article-title":"A novel rexinoid agonist, UAB116, decreases metastatic phenotype in hepatoblastoma by inhibiting the wnt\/\u03b2-catenin pathway via upregulation of TRIM29","volume":"26","author":"Butey","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B132","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41467-017-00101-w","article-title":"TRIM29 promotes DNA virus infections by inhibiting innate immune response","volume":"8","author":"Xing","year":"2017","journal-title":"Nat Commun"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000002047","article-title":"Reduced tripartite motif-containing protein 29 deteriorates the severity of severe acute pancreatitis","volume":"51","author":"Ji","year":"2022","journal-title":"Pancreas"},{"key":"B134","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1038\/s41467-024-44745-x","article-title":"Loss of TRIM29 mitigates viral myocarditis by attenuating PERK-driven ER stress response in male mice","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"key":"B135","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41418-022-01041-9","article-title":"UFL1 promotes antiviral immune response by maintaining STING stability independent of UFMylation","volume":"30","author":"Tao","year":"2023","journal-title":"Cell Death Differ"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.mucimm.2024.10.004","article-title":"TRIM29 controls enteric RNA virus-induced intestinal inflammation by targeting NLRP6 and NLRP9b signaling pathways","volume":"18","author":"Wang","year":"2025","journal-title":"Mucosal Immunol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2023.03.010","article-title":"Neuron stem cell NLRP6 sustains hippocampal neurogenesis to resist stress-induced depression","volume":"13","author":"Tang","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"B139","article-title":"TRIM29 functions as an oncogene in gastric cancer and is regulated by miR-185","volume":"8","author":"Qiu","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.12130","article-title":"Silencing of tripartite motif (TRIM) 29 inhibits proliferation and invasion and increases chemosensitivity to cisplatin in human lung squamous cancer NCI-H520 cells","volume":"6","author":"Liu","year":"2015","journal-title":"Thorac Cancer"},{"key":"B141","doi-asserted-by":"publisher","first-page":"20220711","DOI":"10.1515\/biol-2022-0711","article-title":"TRIM29 knockdown prevented the colon cancer progression through decreasing the ubiquitination levels of KRT5","volume":"18","author":"Sun","year":"2023","journal-title":"Open Life Sci"},{"key":"B142","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41420-023-01491-1","article-title":"TRIM29 hypermethylation drives esophageal cancer progression via suppression of ZNF750","volume":"9","author":"Yi","year":"2023","journal-title":"Cell Death Discov"},{"key":"B143","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2174\/1566524023666230510101525","article-title":"Targeting TRIM29 as a negative regulator of CAR-NK cell effector function to improve antitumor efficacy of these cells: A perspective","volume":"24","author":"Saleh","year":"2024","journal-title":"Curr Mol Med"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15852","article-title":"TRIM29 acts as a potential senescence suppressor with epigenetic activation in nasopharyngeal carcinoma","volume":"114","author":"Yue","year":"2023","journal-title":"Cancer Sci"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.e15533","article-title":"Prediction value of TRIM29 on immunotherapy in colorectal cancer","volume":"40","author":"Han","year":"2022","journal-title":"J Clin Oncol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41419-024-07138-y","article-title":"cNEK6 induces gemcitabine resistance by promoting glycolysis in pancreatic ductal adenocarcinoma via the SNRPA\/PPA2c\/mTORC1 axis","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102294","article-title":"TRIM29 reverses lenvatinib resistance in liver cancer cells by ubiquitinating and degrading YBX1 to inhibit the PI3K\/AKT pathway","volume":"53","author":"Tang","year":"2025","journal-title":"Transl Oncol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-023-01220-5","article-title":"The dual function of cGAS-STING signaling axis in liver diseases","volume":"45","author":"Li","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27185","article-title":"Insulin promotes the phenotype transformation of macrophages during wound healing in diabetes through PI3K\/Akt and PPAR - \u03b3 signal transduction","volume":"234","author":"Yu","year":"2019","journal-title":"J Cell Physiol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.117045","article-title":"Inhibition of JAK-STAT and NF-\u03baB signalling systems could be a novel therapeutic target against insulin resistance and type 2 diabetes","volume":"239","author":"Bako","year":"2019","journal-title":"Life Sci"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0379-y","article-title":"Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NF\u03baB signaling","volume":"33","author":"Fisher","year":"2019","journal-title":"Leukemia"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10051072","article-title":"The role of the metabolism of zinc and manganese ions in human cancerogenesis","volume":"10","author":"Markovich","year":"2022","journal-title":"Biomedicines"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.134210","article-title":"Implications of the cGAS-STING pathway in diabetes: Risk factors and therapeutic strategies","volume":"278","author":"Mohammadi","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100324","article-title":"The role of cGAS-STING signalling in liver diseases","volume":"3","author":"Chen","year":"2021","journal-title":"JHEP Rep"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.719644","article-title":"cGAS-STING signaling pathway and liver disease: from basic research to clinical practice","volume":"12","author":"Chen","year":"2021","journal-title":"Front Pharmacol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1021\/acsabm.3c01305","article-title":"STING-pathway inhibiting nanoparticles (SPINs) as a platform for treatment of inflammatory diseases","volume":"7","author":"Pastora","year":"2024","journal-title":"ACS Appl Bio Mater"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1239142","article-title":"cGAS-STING signaling pathway in intestinal homeostasis and diseases","author":"Yang","year":"2023","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1674018\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:26:25Z","timestamp":1759123585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1674018\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":157,"alternative-id":["10.3389\/fimmu.2025.1674018"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1674018","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"article-number":"1674018"}}